GSK Investigational Site

Piraeus 18537

0 studies enrolling now · 3 studies all time

What they study most

Diabetes Mellitus, HIV Infections, Infection, Human Immunodeficiency Virus, Lung Cancer, Non-Small Cell

Studies at this site

• A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults — Completed
• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
• Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus — Completed